Toshikazu Suzuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Toshikazu Suzuki has a total of 175 co-authors. Here are the top co-authors by number of shared publications:
Michihiko Fujii
Kihara Institute for Biological Research, Yokohama City University, Maioka-cho 641-12, Totsuka-ku, Yokohama 244-0813, Japan
15 shared publicationsDai Ayusawa
11 shared publicationsHideki Ogino
10 shared publicationsEriko Michishita
Kihara Institute for Biological Research and Graduate School of Integrated Science, Yokohama City University Maioka-cho 641-12, Yokohama 244-0813
8 shared publicationsNobuo Suzuki
From the *Department of Environmental Biochemistry, Graduate School of Medicine, Chiba University, Chiba; and †Department of Health and Nutrition, Wayo Women’s University, Ichikawa, Japan
8 shared publications- Kazuei Igarashi
Amine Pharma Research Institute, Innovation Plaza at Chiba University, Chiba 260-0856, Japan
7 shared publications
Latest Publications
- Open Access
- 9 May 2026
- Published by MDPI AG in Applied Sciences
- Vol. 16 (10) , 4679
Performance of Wild Saccharomyces cerevisiae Strains in Enriched-Dough Kouglof
Two wild Saccharomyces cerevisiae strains, 9-3 and 10-2, isolated from nectarine and apple leaves, show high fermentation performance in standard breadmaking but their utility in enriched-dough products remained untested. This study evaluated their performance in kouglof production against a commercial baker’s yeast as a control. Fermentation was monitored by weight loss (reflecting CO2 production) and pH changes. Finished loaves were evaluated for macroscopic traits (weight, height, appearance), crust/crumb color, texture, and microstructure via 3D/2D analysis of gas-cell morphology. Sensory acceptance was also assessed. While size-related traits were similar across all samples, strain 10-2 significantly outperformed 9-3. Kouglof made with 10-2 exhibited commercial-grade softness, characterized by lower hardness and gumminess, lower residual sugar content, and a finer, more uniform gas-cell structure with a darker, well-developed crust, whereas 9-3 yielded a firmer crumb with fewer, larger gas cells. Sensory acceptance was comparable across variants, with all samples rated as highly acceptable. Strain 10-2 demonstrated high sucrose tolerance and performed comparably to or better than the control across multiple product-quality metrics in enriched-dough kouglof. These findings support the potential of wild yeast 10-2 for sweet bread production with high-sucrose and high-fat formulations, though further optimization is warranted.
- 9 May 2026
- Published by MDPI AG in Applied Sciences
- Vol. 16 (10) , 4679
Open AccessPerformance of Wild Saccharomyces cerevisiae Strains in Enriched-Dough Kouglof
Two wild Saccharomyces cerevisiae strains, 9-3 and 10-2, isolated from nectarine and apple leaves, show high fermentation performance in standard breadmaking but their utility in enriched-dough products remained untested. This study evaluated their performance in kouglof production against a commercial baker’s yeast as a control. Fermentation was monitored by weight loss (reflecting CO2 production) and pH changes. Finished loaves were evaluated for macroscopic traits (weight, height, appearance), crust/crumb color, texture, and microstructure via 3D/2D analysis of gas-cell morphology. Sensory acceptance was also assessed. While size-related traits were similar across all samples, strain 10-2 significantly outperformed 9-3. Kouglof made with 10-2 exhibited commercial-grade softness, characterized by lower hardness and gumminess, lower residual sugar content, and a finer, more uniform gas-cell structure with a darker, well-developed crust, whereas 9-3 yielded a firmer crumb with fewer, larger gas cells. Sensory acceptance was comparable across variants, with all samples rated as highly acceptable. Strain 10-2 demonstrated high sucrose tolerance and performed comparably to or better than the control across multiple product-quality metrics in enriched-dough kouglof. These findings support the potential of wild yeast 10-2 for sweet bread production with high-sucrose and high-fat formulations, though further optimization is warranted.
- Open Access
Compounds Contributing to the Modulation of Visceral Adiposity and Hepatic Lipid Metabolism in High-Fat-Diet-Fed Rats by Pometia pinnata (Matoa) Peel Powder: Identification of Pancreatic Lipase Inhibitors
Background: Pometia pinnata (matoa) peel powder attenuates high-fat diet-induced adiposity and hepatic lipid accumulation in rats, but the responsible compounds remain unclear. This study aimed to identify the bioactive compounds that may contribute to this phenotype, with an emphasis on pancreatic lipase inhibition as a candidate mechanism. Methods: Rats received high-fat diets containing matoa peel powder, or its water- or ethanol extraction residue. Visceral fat accumulation, hepatic lipid deposition, and serum lipid profiles were evaluated. An ethanol extract was fractionated by activity-guided column chromatography based on pancreatic lipase-inhibitory activity, and structures were identified by nuclear magnetic resonance analysis. Static in vitro gastrointestinal digestion was performed to assess inhibition of fatty acid release by the extract or isolated compounds. Results: The visceral adiposity- and hepatic lipid-modulating effects observed with matoa peel powder were retained in the water extraction residue but not in the ethanol extraction residue, suggesting removal of bioactive constituents by ethanol extraction. The ethanol extract inhibited pancreatic lipase (IC50 = 740 µg/mL). Two active compounds—hederagenin saponin and protocatechuic acid—were isolated, and both inhibited pancreatic lipase (IC50 = 149 µmol/L and 404 µmol/L, respectively). Under simulated digestion in vitro, the ethanol extract and protocatechuic acid reduced free fatty acid release, whereas hederagenin saponin did not. Conclusions: Matoa peel powder contains ethanol-soluble constituents, including pancreatic lipase-inhibitory compounds that may contribute to the modulation of adiposity and hepatic lipid metabolism in high-fat-diet-fed rats. The attenuation of individual-compound activity under simulated digestion is consistent with matrix- and intestinal milieu-dependent effects, and supports a multi-component mechanism involving saponins, phenolics (protocatechuic acid), and their intestinal biotransformation products.
Open AccessCompounds Contributing to the Modulation of Visceral Adiposity and Hepatic Lipid Metabolism in High-Fat-Diet-Fed Rats by Pometia pinnata (Matoa) Peel Powder: Identification of Pancreatic Lipase Inhibitors
Background: Pometia pinnata (matoa) peel powder attenuates high-fat diet-induced adiposity and hepatic lipid accumulation in rats, but the responsible compounds remain unclear. This study aimed to identify the bioactive compounds that may contribute to this phenotype, with an emphasis on pancreatic lipase inhibition as a candidate mechanism. Methods: Rats received high-fat diets containing matoa peel powder, or its water- or ethanol extraction residue. Visceral fat accumulation, hepatic lipid deposition, and serum lipid profiles were evaluated. An ethanol extract was fractionated by activity-guided column chromatography based on pancreatic lipase-inhibitory activity, and structures were identified by nuclear magnetic resonance analysis. Static in vitro gastrointestinal digestion was performed to assess inhibition of fatty acid release by the extract or isolated compounds. Results: The visceral adiposity- and hepatic lipid-modulating effects observed with matoa peel powder were retained in the water extraction residue but not in the ethanol extraction residue, suggesting removal of bioactive constituents by ethanol extraction. The ethanol extract inhibited pancreatic lipase (IC50 = 740 µg/mL). Two active compounds—hederagenin saponin and protocatechuic acid—were isolated, and both inhibited pancreatic lipase (IC50 = 149 µmol/L and 404 µmol/L, respectively). Under simulated digestion in vitro, the ethanol extract and protocatechuic acid reduced free fatty acid release, whereas hederagenin saponin did not. Conclusions: Matoa peel powder contains ethanol-soluble constituents, including pancreatic lipase-inhibitory compounds that may contribute to the modulation of adiposity and hepatic lipid metabolism in high-fat-diet-fed rats. The attenuation of individual-compound activity under simulated digestion is consistent with matrix- and intestinal milieu-dependent effects, and supports a multi-component mechanism involving saponins, phenolics (protocatechuic acid), and their intestinal biotransformation products.
- Open Access
Extent of Unidentified Complaints and Depression Is Inversely Associated with Fish and Shellfish Intake in Young Japanese Women
Background/Objectives: Vague physical complaints with no corresponding organic disease background are called unidentified complaints. The symptoms of patients with unidentified complaints closely resemble medically unexplained or persistent physical symptoms, with the onset sometimes masked by mental disorders. Over the past 50 years, numerous studies have connected unfavorable eating habits to these symptoms; however, no study has systematically examined the association between the symptoms and specific nutrients or food items. Methods: We conducted a cross-sectional study of young Japanese women, using questionnaire surveys, to assess their nutritional intake, quantify unidentified complaints and depression, and identify nutrients/food items primarily associated with the severity of these conditions. Results: Our findings indicate that participants with high scores for unidentified complaints, depression, or both had lower intake levels of eicosapentaenoic acid, docosahexaenoic acid, vitamin D, and vitamin B12 than those with low scores, alongside reduced fish and shellfish consumption. Notably, the median fish and shellfish intake in the group with high scores for both unidentified complaints and depression was less than one-fourth of that in the low-score group. Conclusions: The results align with previous findings, demonstrating a modest inverse association between fish intake and depression risk, and suggesting the involvement of fish and shellfish intake in the occurrence of unidentified complaints.
Open AccessExtent of Unidentified Complaints and Depression Is Inversely Associated with Fish and Shellfish Intake in Young Japanese Women
Background/Objectives: Vague physical complaints with no corresponding organic disease background are called unidentified complaints. The symptoms of patients with unidentified complaints closely resemble medically unexplained or persistent physical symptoms, with the onset sometimes masked by mental disorders. Over the past 50 years, numerous studies have connected unfavorable eating habits to these symptoms; however, no study has systematically examined the association between the symptoms and specific nutrients or food items. Methods: We conducted a cross-sectional study of young Japanese women, using questionnaire surveys, to assess their nutritional intake, quantify unidentified complaints and depression, and identify nutrients/food items primarily associated with the severity of these conditions. Results: Our findings indicate that participants with high scores for unidentified complaints, depression, or both had lower intake levels of eicosapentaenoic acid, docosahexaenoic acid, vitamin D, and vitamin B12 than those with low scores, alongside reduced fish and shellfish consumption. Notably, the median fish and shellfish intake in the group with high scores for both unidentified complaints and depression was less than one-fourth of that in the low-score group. Conclusions: The results align with previous findings, demonstrating a modest inverse association between fish intake and depression risk, and suggesting the involvement of fish and shellfish intake in the occurrence of unidentified complaints.
- Open Access
Effect of a Two-Week Diet without Meat and Poultry on Serum Coenzyme Q10 Levels
Coenzyme Q10 (CoQ10) is an essential compound for energy production in the mitochondria and the antioxidation of lipid-soluble substances in cells. As it can be biosynthesized in cells, CoQ10 is not an essential nutrient. However, its intake through meals contributes to the maintenance of CoQ10 levels in the body. Therefore, understanding the effects of daily diet on serum CoQ10 levels is crucial. This study investigated the effect of a two-week diet without meat or poultry, which are rich in CoQ10 content, on serum CoQ10 levels of 22 young women aged 20–21 years. Upon restricting the intake of meat and poultry, the participants’ average daily intake of CoQ10 from meals decreased from 2.1 ± 0.6 to 1.1 ± 0.5 mg/day. Simultaneously, the average serum reduced, oxidized, and total CoQ10 levels decreased by 14%, 31%, and 16%, respectively, after the two-week dietary intervention, whereas the reduced serum CoQ10 ratio increased significantly. These results suggest that meat and poultry are significant sources of CoQ10 in the diet. Dietary habits affect serum CoQ10 levels; however, further research is required to determine whether people who follow long-term diets with lower serum CoQ10 levels, such as a healthy reference diet proposed by the EAT-Lancet Commission in addition to vegetarian and vegan diets, need CoQ10 supplementation to maintain health and achieve healthy longevity.
Open AccessEffect of a Two-Week Diet without Meat and Poultry on Serum Coenzyme Q10 Levels
Coenzyme Q10 (CoQ10) is an essential compound for energy production in the mitochondria and the antioxidation of lipid-soluble substances in cells. As it can be biosynthesized in cells, CoQ10 is not an essential nutrient. However, its intake through meals contributes to the maintenance of CoQ10 levels in the body. Therefore, understanding the effects of daily diet on serum CoQ10 levels is crucial. This study investigated the effect of a two-week diet without meat or poultry, which are rich in CoQ10 content, on serum CoQ10 levels of 22 young women aged 20–21 years. Upon restricting the intake of meat and poultry, the participants’ average daily intake of CoQ10 from meals decreased from 2.1 ± 0.6 to 1.1 ± 0.5 mg/day. Simultaneously, the average serum reduced, oxidized, and total CoQ10 levels decreased by 14%, 31%, and 16%, respectively, after the two-week dietary intervention, whereas the reduced serum CoQ10 ratio increased significantly. These results suggest that meat and poultry are significant sources of CoQ10 in the diet. Dietary habits affect serum CoQ10 levels; however, further research is required to determine whether people who follow long-term diets with lower serum CoQ10 levels, such as a healthy reference diet proposed by the EAT-Lancet Commission in addition to vegetarian and vegan diets, need CoQ10 supplementation to maintain health and achieve healthy longevity.
- Open Access
CYP7A1, NPC1L1, ABCB1, and CD36 Polymorphisms Associated with Coenzyme Q10 Availability Affect the Subjective Quality of Life Score (SF-36) after Long-Term CoQ10 Supplementation in Women
The single nucleotide polymorphisms (SNPs) rs3808607, rs2072183, rs2032582, and rs1761667 are associated with coenzyme Q10 (CoQ10) bioavailability in women after long-term CoQ10 supplementation. However, the beneficial aspects of the association between these SNPs and CoQ10 supplementation remain unknown. We investigated their relationship using the subjective quality of life score SF-36 by reanalyzing previous data from 92 study participants who were receiving ubiquinol (a reduced form of CoQ10) supplementation for 1 year. Two-way repeated-measures analysis of variance revealed a significant interaction between rs1761667 and the SF-36 scores of role physical (p = 0.016) and mental health (p = 0.017) in women. Subgrouping of participants based on the above four SNPs revealed significant interactions between these SNPs and the SF-36 scores of general health (p = 0.045), role emotional (p = 0.008), and mental health (p = 0.019) and increased serum CoQ10 levels (p = 0.008), suggesting that the benefits of CoQ10 supplementation, especially in terms of psychological parameters, are genotype-dependent in women. However, significant interactions were not observed in men. Therefore, inclusion of SNP subgrouping information in clinical trials of CoQ10 supplementation may provide conclusive evidence supporting other beneficial health effects exerted by the association between these SNPs and CoQ10 on women.
Open AccessCYP7A1, NPC1L1, ABCB1, and CD36 Polymorphisms Associated with Coenzyme Q10 Availability Affect the Subjective Quality of Life Score (SF-36) after Long-Term CoQ10 Supplementation in Women
The single nucleotide polymorphisms (SNPs) rs3808607, rs2072183, rs2032582, and rs1761667 are associated with coenzyme Q10 (CoQ10) bioavailability in women after long-term CoQ10 supplementation. However, the beneficial aspects of the association between these SNPs and CoQ10 supplementation remain unknown. We investigated their relationship using the subjective quality of life score SF-36 by reanalyzing previous data from 92 study participants who were receiving ubiquinol (a reduced form of CoQ10) supplementation for 1 year. Two-way repeated-measures analysis of variance revealed a significant interaction between rs1761667 and the SF-36 scores of role physical (p = 0.016) and mental health (p = 0.017) in women. Subgrouping of participants based on the above four SNPs revealed significant interactions between these SNPs and the SF-36 scores of general health (p = 0.045), role emotional (p = 0.008), and mental health (p = 0.019) and increased serum CoQ10 levels (p = 0.008), suggesting that the benefits of CoQ10 supplementation, especially in terms of psychological parameters, are genotype-dependent in women. However, significant interactions were not observed in men. Therefore, inclusion of SNP subgrouping information in clinical trials of CoQ10 supplementation may provide conclusive evidence supporting other beneficial health effects exerted by the association between these SNPs and CoQ10 on women.
- Open Access
Anti-Obesity Effects of Matoa (Pometia pinnata) Fruit Peel Powder in High-Fat Diet-Fed Rats
Fruit peels, pericarps, or rinds are rich in phenolic/polyphenolic compounds with antioxidant properties and potentially beneficial effects against obesity and obesity-related non-communicable diseases. This study investigated the anti-obesity effects of matoa (Pometia pinnata) and salak (Salacca zalacca) fruit peel. Neither matoa peel powder (MPP) nor salak peel powder (SPP) affected the body weight, visceral fat weight, or serum glucose or lipid levels of Sprague–Dawley rats when included as 1% (w/w) of a high-fat diet (HFD). However, MPP significantly decreased the hepatic lipid level. MPP at a dose of 3% (w/w) of the HFD decreased body weight, visceral fat, and serum triglyceride levels as well as the hepatic lipid content. The inhibitory effect of MPP on hepatic lipid accumulation was not enhanced when its concentration was increased from 1% to 3% of the HFD. The anti-obesity effect of matoa was partly explained by the inhibitory effect of the matoa peel extract on fatty acid-induced secretion of ApoB-48 protein, a marker of intestinal chylomicrons, in differentiated Caco-2 cell monolayers. We identified hederagenin saponins that are abundant in MPP as potential anti-obesity substances. These results will contribute towards the development of functional foods with anti-obesity effects using the matoa fruit peel.
Open AccessAnti-Obesity Effects of Matoa (Pometia pinnata) Fruit Peel Powder in High-Fat Diet-Fed Rats
Fruit peels, pericarps, or rinds are rich in phenolic/polyphenolic compounds with antioxidant properties and potentially beneficial effects against obesity and obesity-related non-communicable diseases. This study investigated the anti-obesity effects of matoa (Pometia pinnata) and salak (Salacca zalacca) fruit peel. Neither matoa peel powder (MPP) nor salak peel powder (SPP) affected the body weight, visceral fat weight, or serum glucose or lipid levels of Sprague–Dawley rats when included as 1% (w/w) of a high-fat diet (HFD). However, MPP significantly decreased the hepatic lipid level. MPP at a dose of 3% (w/w) of the HFD decreased body weight, visceral fat, and serum triglyceride levels as well as the hepatic lipid content. The inhibitory effect of MPP on hepatic lipid accumulation was not enhanced when its concentration was increased from 1% to 3% of the HFD. The anti-obesity effect of matoa was partly explained by the inhibitory effect of the matoa peel extract on fatty acid-induced secretion of ApoB-48 protein, a marker of intestinal chylomicrons, in differentiated Caco-2 cell monolayers. We identified hederagenin saponins that are abundant in MPP as potential anti-obesity substances. These results will contribute towards the development of functional foods with anti-obesity effects using the matoa fruit peel.
- Open Access
- 11 March 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (3) , 431
CYP7A1, NPC1L1, ABCB1, and CD36 Polymorphisms Are Associated with Increased Serum Coenzyme Q10 after Long-Term Supplementation in Women
Coenzyme Q10 (CoQ10), an essential component for energy production that exhibits antioxidant activity, is considered a health-supporting and antiaging supplement. However, intervention-controlled studies have provided variable results on CoQ10 supplementation benefits, which may be attributed to individual CoQ10 bioavailability differences. This study aimed to investigate the relationship between genetic polymorphisms and CoQ10 serum levels after long-term supplementation. CoQ10 levels at baseline and after one year of supplementation (150 mg) were determined, and eight single nucleotide polymorphisms (SNPs) in cholesterol metabolism and CoQ10 absorption, efflux, and cellular uptake related genes were assessed. Rs2032582 (ABCB1) and rs1761667 (CD36) were significantly associated with a higher increase in CoQ10 levels in women. In addition, in women, rs3808607 (CYP7A1) and rs2072183 (NPC1L1) were significantly associated with a higher increase in CoQ10 per total cholesterol levels. Subgroup analyses showed that these four SNPs were useful for classifying high- or low-responder to CoQ10 bioavailability after long-term supplementation among women, but not in men. On the other hand, in men, no SNP was found to be significantly associated with increased serum CoQ10. These results collectively provide novel evidence on the relationship between genetics and CoQ10 bioavailability after long-term supplementation, which may help understand and assess CoQ10 supplementation effects, at least in women.
- 11 March 2021
- Published by MDPI AG in Antioxidants
- Vol. 10 (3) , 431
Open AccessCYP7A1, NPC1L1, ABCB1, and CD36 Polymorphisms Are Associated with Increased Serum Coenzyme Q10 after Long-Term Supplementation in Women
Coenzyme Q10 (CoQ10), an essential component for energy production that exhibits antioxidant activity, is considered a health-supporting and antiaging supplement. However, intervention-controlled studies have provided variable results on CoQ10 supplementation benefits, which may be attributed to individual CoQ10 bioavailability differences. This study aimed to investigate the relationship between genetic polymorphisms and CoQ10 serum levels after long-term supplementation. CoQ10 levels at baseline and after one year of supplementation (150 mg) were determined, and eight single nucleotide polymorphisms (SNPs) in cholesterol metabolism and CoQ10 absorption, efflux, and cellular uptake related genes were assessed. Rs2032582 (ABCB1) and rs1761667 (CD36) were significantly associated with a higher increase in CoQ10 levels in women. In addition, in women, rs3808607 (CYP7A1) and rs2072183 (NPC1L1) were significantly associated with a higher increase in CoQ10 per total cholesterol levels. Subgroup analyses showed that these four SNPs were useful for classifying high- or low-responder to CoQ10 bioavailability after long-term supplementation among women, but not in men. On the other hand, in men, no SNP was found to be significantly associated with increased serum CoQ10. These results collectively provide novel evidence on the relationship between genetics and CoQ10 bioavailability after long-term supplementation, which may help understand and assess CoQ10 supplementation effects, at least in women.
- Open Access
- 7 January 2020
- Published by Hindawi Limited in Journal of Nutrition and Metabolism
- Vol. 2020, 1-7
Miso Soup Consumption Enhances the Bioavailability of the Reduced Form of Supplemental Coenzyme Q10
Coenzyme Q10 (CoQ10) is an essential compound that is involved in energy production and is a lipid-soluble antioxidant. Although it has been proposed as an antiaging and a health-supporting supplement, its low bioavailability remains a significant issue. Concurrent food intake enhances the absorption of orally administered CoQ10, but it has not been fully established whether specific food substances affect intestinal CoQ10 absorption. Therefore, to determine whether the bioavailability of supplemental CoQ10 is affected by diet, P30, a granulated and reduced form of CoQ10, was dispersed in four different foods, clear soup, miso soup, milk soup, and raw egg sauce. Those foods which contained CoQ10 were consumed on different occasions at intervals of 6–14 weeks by the same participants. Thirteen participants were recruited in the single-dose and repeated clinical study. When miso soup containing P30 was provided, the serum CoQ10 concentration increased faster than when participants consumed other P30-containing soups or a P30-containing raw egg sauce. The area under the curve for serum CoQ10 during the first 5 h after consumption of the P30-containing miso soup was approximately 1.5 times larger than those after the consumption of other P30-containing meals. These data imply that the absorption of CoQ10 supplements can be enhanced by consuming them with food and in particular with specific food substances, such as miso soup.
- 7 January 2020
- Published by Hindawi Limited in Journal of Nutrition and Metabolism
- Vol. 2020, 1-7
Open AccessMiso Soup Consumption Enhances the Bioavailability of the Reduced Form of Supplemental Coenzyme Q10
Coenzyme Q10 (CoQ10) is an essential compound that is involved in energy production and is a lipid-soluble antioxidant. Although it has been proposed as an antiaging and a health-supporting supplement, its low bioavailability remains a significant issue. Concurrent food intake enhances the absorption of orally administered CoQ10, but it has not been fully established whether specific food substances affect intestinal CoQ10 absorption. Therefore, to determine whether the bioavailability of supplemental CoQ10 is affected by diet, P30, a granulated and reduced form of CoQ10, was dispersed in four different foods, clear soup, miso soup, milk soup, and raw egg sauce. Those foods which contained CoQ10 were consumed on different occasions at intervals of 6–14 weeks by the same participants. Thirteen participants were recruited in the single-dose and repeated clinical study. When miso soup containing P30 was provided, the serum CoQ10 concentration increased faster than when participants consumed other P30-containing soups or a P30-containing raw egg sauce. The area under the curve for serum CoQ10 during the first 5 h after consumption of the P30-containing miso soup was approximately 1.5 times larger than those after the consumption of other P30-containing meals. These data imply that the absorption of CoQ10 supplements can be enhanced by consuming them with food and in particular with specific food substances, such as miso soup.
- Open Access
- 2 October 2016
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 80 (10) , 1883-1886
Inhibitory effect of 13 taxane diterpenoids from Chinese yew (Taxus chinensis var. mairei) on the proliferation of HeLa cervical cancer cells
The inhibitory effect of 13 taxanes isolated from the Chinese yew (Taxus chinensis var. mairei) on the proliferation of human cervical cancer HeLa cells were examined using an MTT assay. Four compounds having a hydrophobic cinnamate side chain showed antiproliferative activity, which may be due to increased cell permeability.
- 2 October 2016
- Published by Taylor & Francis in Bioscience, Biotechnology, and Biochemistry
- Vol. 80 (10) , 1883-1886
Open AccessInhibitory effect of 13 taxane diterpenoids from Chinese yew (Taxus chinensis var. mairei) on the proliferation of HeLa cervical cancer cells
The inhibitory effect of 13 taxanes isolated from the Chinese yew (Taxus chinensis var. mairei) on the proliferation of human cervical cancer HeLa cells were examined using an MTT assay. Four compounds having a hydrophobic cinnamate side chain showed antiproliferative activity, which may be due to increased cell permeability.
- 1 November 2012
- Published by Wolters Kluwer Health in Pancreas
- Vol. 41 (8) , 1247-1254
Extracellular Release of Annexin II From Pancreatic Cancer Cells and Resistance to Anticancer Drug–Induced Apoptosis by Supplementation of Recombinant Annexin II
Objectives Extracellular microenvironment plays crucial roles in the development of cancers and chemoresistance. Pancreatic carcinoma is resistant to almost all chemotherapeutic agents. In this study, we identified annexin II in the medium from pancreatic cancer cells as a protein released into the extracellular environment. Methods Medium from 5-hour cultures of various cancer cells was collected. Proteins in the medium were detected by molecular mass analysis and immunoblotting. Anticancer drug sensitivity of cells preincubated with or without recombinant annexin II (rANX II) was measured using crystal violet assay and colony survival assay. Apoptosis-related molecules were analyzed by immunoblotting. Results Recombinant ANX II supplementation in the medium confers resistance to anticancer drugs, including cisplatin, 5-fluorouracil, and gemcitabine, in MiaPaCa-2 and AsPC-1 cells. In MiaPaCa-2 cells, rANX II supplementation resulted in suppression of caspase-3 activation associated with increased Bcl-2/Bax ratios. Suppression of cisplatin-induced cell death by rANX II supplementation was canceled by inhibitors of phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase signal pathways. Conclusions The current study is the first report to demonstrate that supplementation of rANX II in the medium increased resistance to anticancer drugs in pancreatic cancer cells. Recombinant ANX II exerts cell death–suppressive function by antagonizing cisplatin-induced apoptosis.
- 1 November 2012
- Published by Wolters Kluwer Health in Pancreas
- Vol. 41 (8) , 1247-1254
Extracellular Release of Annexin II From Pancreatic Cancer Cells and Resistance to Anticancer Drug–Induced Apoptosis by Supplementation of Recombinant Annexin II
Objectives Extracellular microenvironment plays crucial roles in the development of cancers and chemoresistance. Pancreatic carcinoma is resistant to almost all chemotherapeutic agents. In this study, we identified annexin II in the medium from pancreatic cancer cells as a protein released into the extracellular environment. Methods Medium from 5-hour cultures of various cancer cells was collected. Proteins in the medium were detected by molecular mass analysis and immunoblotting. Anticancer drug sensitivity of cells preincubated with or without recombinant annexin II (rANX II) was measured using crystal violet assay and colony survival assay. Apoptosis-related molecules were analyzed by immunoblotting. Results Recombinant ANX II supplementation in the medium confers resistance to anticancer drugs, including cisplatin, 5-fluorouracil, and gemcitabine, in MiaPaCa-2 and AsPC-1 cells. In MiaPaCa-2 cells, rANX II supplementation resulted in suppression of caspase-3 activation associated with increased Bcl-2/Bax ratios. Suppression of cisplatin-induced cell death by rANX II supplementation was canceled by inhibitors of phosphatidylinositol 3-kinase and mitogen-activated protein kinase kinase signal pathways. Conclusions The current study is the first report to demonstrate that supplementation of rANX II in the medium increased resistance to anticancer drugs in pancreatic cancer cells. Recombinant ANX II exerts cell death–suppressive function by antagonizing cisplatin-induced apoptosis.